JPMorgan Chase & Co’s Revance Therapeutics, Inc. RVNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,298,822
Closed -$3.95M 6682
2024
Q4
$3.95M Buy
1,298,822
+1,164,641
+868% +$3.54M ﹤0.01% 2933
2024
Q3
$696K Sell
134,181
-2,810,680
-95% -$14.6M ﹤0.01% 3850
2024
Q2
$7.57M Sell
2,944,861
-208,262
-7% -$535K ﹤0.01% 2280
2024
Q1
$15.5M Sell
3,153,123
-1,490,296
-32% -$7.33M ﹤0.01% 1849
2023
Q4
$40.8M Buy
4,643,419
+13,222
+0.3% +$116K ﹤0.01% 1201
2023
Q3
$53.1M Sell
4,630,197
-63,691
-1% -$731K 0.01% 989
2023
Q2
$119M Sell
4,693,888
-470,269
-9% -$11.9M 0.01% 704
2023
Q1
$166M Buy
5,164,157
+149,735
+3% +$4.82M 0.02% 559
2022
Q4
$92.6M Sell
5,014,422
-436,076
-8% -$8.05M 0.01% 733
2022
Q3
$147M Sell
5,450,498
-1,237,427
-19% -$33.4M 0.02% 546
2022
Q2
$92.4M Sell
6,687,925
-129,280
-2% -$1.79M 0.01% 731
2022
Q1
$133M Sell
6,817,205
-109,201
-2% -$2.13M 0.02% 678
2021
Q4
$113M Buy
6,926,406
+1,844,101
+36% +$30.1M 0.01% 765
2021
Q3
$142M Buy
5,082,305
+38,734
+0.8% +$1.08M 0.02% 661
2021
Q2
$149M Buy
5,043,571
+609,745
+14% +$18.1M 0.02% 668
2021
Q1
$124M Buy
4,433,826
+107,773
+2% +$3.01M 0.02% 704
2020
Q4
$123M Buy
4,326,053
+246,997
+6% +$7M 0.02% 657
2020
Q3
$105M Buy
4,079,056
+51,282
+1% +$1.32M 0.02% 632
2020
Q2
$98.4M Buy
4,027,774
+113,176
+3% +$2.76M 0.02% 627
2020
Q1
$57.9M Sell
3,914,598
-109,559
-3% -$1.62M 0.01% 707
2019
Q4
$65.3M Buy
4,024,157
+1,369,385
+52% +$22.2M 0.01% 759
2019
Q3
$34.5M Buy
2,654,772
+179,869
+7% +$2.34M 0.01% 1043
2019
Q2
$31.3M Sell
2,474,903
-1,422,967
-37% -$18M 0.01% 1103
2019
Q1
$61.4M Buy
3,897,870
+92,811
+2% +$1.46M 0.01% 788
2018
Q4
$76.6M Buy
3,805,059
+158,448
+4% +$3.19M 0.02% 658
2018
Q3
$90.6M Sell
3,646,611
-18,836
-0.5% -$468K 0.02% 690
2018
Q2
$101M Buy
3,665,447
+228,030
+7% +$6.26M 0.02% 610
2018
Q1
$106M Sell
3,437,417
-120,562
-3% -$3.71M 0.02% 571
2017
Q4
$127M Buy
3,557,979
+11,712
+0.3% +$419K 0.03% 510
2017
Q3
$96.6M Sell
3,546,267
-80,336
-2% -$2.19M 0.02% 600
2017
Q2
$95.7M Buy
3,626,603
+166,759
+5% +$4.4M 0.02% 595
2017
Q1
$72M Buy
3,459,844
+29,686
+0.9% +$617K 0.02% 691
2016
Q4
$71M Buy
3,430,158
+162,457
+5% +$3.36M 0.02% 657
2016
Q3
$53M Sell
3,267,701
-59,321
-2% -$962K 0.01% 733
2016
Q2
$45.2M Buy
3,327,022
+298,448
+10% +$4.06M 0.01% 798
2016
Q1
$52.9M Buy
3,028,574
+94,432
+3% +$1.65M 0.01% 713
2015
Q4
$100M Buy
2,934,142
+1,539,363
+110% +$52.6M 0.03% 520
2015
Q3
$41.5M Sell
1,394,779
-1,726
-0.1% -$51.4K 0.01% 805
2015
Q2
$44.7M Buy
1,396,505
+171,942
+14% +$5.5M 0.01% 868
2015
Q1
$25.4M Buy
1,224,563
+502,287
+70% +$10.4M 0.01% 1174
2014
Q4
$12.2M Sell
722,276
-68,541
-9% -$1.16M ﹤0.01% 1572
2014
Q3
$15.3M Buy
790,817
+115,219
+17% +$2.23M ﹤0.01% 1419
2014
Q2
$23M Buy
675,598
+406,398
+151% +$13.8M 0.01% 1233
2014
Q1
$8.48M Buy
+269,200
New +$8.48M ﹤0.01% 1773